Survodutide 10 mg | Pure Lab Peptides Supply
Details, Specifications, and Documents
Description
Buy Survodutide 10 mg for Laboratory Research
Purchase Survodutide 10 mg from Pure Lab Peptides Supply for laboratory research involving glucagon-receptor and glucagon-like peptide-1 (GLP-1) receptor signaling. This research material is supplied as lyophilized powder in one boxed 3 mL vial.
Survodutide, also known as BI 456906 in development studies, is a synthetic dual-receptor agonist investigated for its activity at glucagon and GLP-1 receptors. Researchers have examined its receptor activity using cell-based assays and preclinical experimental models.
The 10 mg label identifies the stated quantity of the named research material. It does not represent separate quantities for each receptor target or establish biological potency. Review the product information and available analytical documentation before selecting this material for laboratory research.
Product Overview
- Product name: Survodutide
- Labeled material amount: 10 mg
- Presentation: One boxed 3 mL vial
- Physical format: Lyophilized powder
- Development identifier: BI 456906
- Research classification: Dual glucagon and GLP-1 receptor agonist
- Intended use: Laboratory research
- Documentation: Available product and batch records, where provided
The 3 mL measurement refers to the vial’s container capacity, not the volume of liquid supplied or the concentration of a prepared solution. Always distinguish the labeled material quantity from container capacity and verify the supplied chemical form using applicable documentation.
Survodutide and Mazdutide: Understanding the Difference
Survodutide and mazdutide share an overlapping research context because both have been investigated in relation to glucagon and GLP-1 receptor signaling. However, they are distinct molecular compounds.
If your laboratory protocol specifies Survodutide, select the corresponding material rather than assuming that another analog is interchangeable. Similar labeled quantities, shared receptor targets, or related research applications do not establish equivalent molecular properties or biological activity.
For comparison, review Mazdutide 10 mg and compare the relevant product specifications and documentation.
Research Background: Dual-Receptor Activity
Published preclinical research has investigated BI 456906 through functional receptor assays and animal models.
In the original study by Zimmermann and colleagues, researchers examined receptor activity using cell-based assays, including measurements of cyclic adenosine monophosphate (cAMP) responses. They also investigated target engagement in mouse models.
The researchers evaluated glucagon-receptor and GLP-1-receptor responses separately. This approach helps characterize the activity profile of a dual agonist because a result involving one receptor does not independently establish activity at the other.
These findings describe the specific materials and experimental conditions used in the published study. They do not independently verify the identity, purity, or functional activity of a commercial batch. Likewise, preclinical findings should not be interpreted as evidence of clinical outcomes.
Product Specifications
| Specification | Details |
|---|---|
| Product name | Survodutide |
| Labeled quantity | 10 mg |
| Development identifier | BI 456906 |
| Research classification | Dual glucagon and GLP-1 receptor agonist |
| Physical format | Lyophilized powder |
| Container | One boxed 3 mL vial |
| Research focus | Glucagon and GLP-1 receptor signaling |
| Analytical documentation | Review available batch-specific records |
| Intended use | Laboratory research only |
Confirm additional technical details, including the reference sequence, molecular formula, molecular weight, chemical form, purity, and storage requirements, against reliable product-specific documentation before publishing or using them in calculations.
COA & Documents
Survodutide 10 mg Certificate of Analysis
Before selecting Survodutide 10 mg, review the available COA & Documents for relevant product records and analytical reports.
Where a batch-specific certificate is available, match the lot number and product presentation to the material under consideration. Check which analytical methods the report uses and what each method establishes.
Three properties deserve particular attention:
- Identity: Evidence that the tested material corresponds to the named compound.
- Chromatographic purity: The reported proportion of relevant chromatographic signal under the specified method.
- Measured content: The amount of material established by the applicable analytical procedure.
These properties are not interchangeable. In particular, a high chromatographic purity result does not establish functional receptor activity or demonstrate equivalent potency compared with another research analog.
Storage and Laboratory Documentation
Use the applicable product records and laboratory procedures to determine appropriate storage conditions, handling requirements, and material-specific stability. Do not assume that storage recommendations for another peptide or analog automatically apply to Survodutide.
Similarly, the vial’s 3 mL capacity does not determine a preparation volume or concentration. Any laboratory calculations should rely on verified material information and an appropriate validated protocol.
Order Survodutide 10 mg from Pure Lab Peptides Supply
Review the available product information and analytical documentation when evaluating Survodutide 10 mg research material for your laboratory inventory.
Visit Pure Lab Peptides Supply to explore the catalog and compare available research materials.
Research-use notice: This material is intended for laboratory research only. It is not intended for human or veterinary consumption, self-administration, or use as a drug, food, or dietary supplement.

















